Phase 4
N=124
Moxifloxacin vs. Polytrim for Conjunctivitis
Conjunctivitis
Bottom Line
View on ClinicalTrials.gov: NCT00581542 ↗Enrolled (actual)
124
Serious AEs
0.0%
Results posted
Jan 2016
Primary outcome: Primary: Number of Participants With Normal Physical Examination of the Eye — 49; 37 participants
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- moxifloxacin (Drug); polytrim (Drug)
- Age
- Pediatric, Adult · 1+ yrs
- Sex
- All
- Sponsor
- University of Rochester
- Primary completion
- Mar 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Normal Physical Examination of the Eye |
49; 37 | — |
| SECONDARY Number of Participants With a Negative Bacterial Culture |
22; 19 | — |
Summary
The purpose of the study is to compare the effect of Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications are approved by the Food and Drug Administration, for treatment of conjunctivitis. This study will investigate if both of the medications are equally good.
Eligibility Criteria
Inclusion Criteria
- 1 - 18 years of age with presumed bacterial conjunctivitis.
Exclusion Criteria
- Previous antibiotics or to receive systemic antibiotic.
Data sourced from ClinicalTrials.gov (NCT00581542). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.